Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jeffery C. Fink"'
Autor:
Brian Kwan, Tobias Fuhrer, Daniel Montemayor, Jeffery C. Fink, Jiang He, Chi-yuan Hsu, Karen Messer, Robert G. Nelson, Minya Pu, Ana C. Ricardo, Hernan Rincon-Choles, Vallabh O. Shah, Hongping Ye, Jing Zhang, Kumar Sharma, Loki Natarajan
Publikováno v:
BMC Bioinformatics, Vol 24, Iss 1, Pp 1-17 (2023)
Abstract Background The growing amount of high dimensional biomolecular data has spawned new statistical and computational models for risk prediction and disease classification. Yet, many of these methods do not yield biologically interpretable model
Externí odkaz:
https://doaj.org/article/bee1d5f2d8c94badb9b1c668170e67ba
Publikováno v:
American Journal of Nephrology. 50:72-80
Background: Adverse safety events (ASE) during hospitalization may contribute to renal decline or poor outcomes. Understanding factors contributing to ASE in chronic kidney disease (CKD) is limited. The objective is to compare differences and determi
Autor:
Jacob B. Blumenthal, Anne Slaven, Rebecca M. Doerfler, Clarissa J. Diamantidis, Jonathan J. Taliercio, Eva Lustigova, Wolfgang C. Winkelmayer, Min Zhan, Chi-yuan Hsu, Corinne Woods, Louise Strauss, Wendy L. St. Peter, Jeffery C. Fink, Akinlolu O. Ojo, Dawei Xie, James P. Lash, Erin B. Mahone
Publikováno v:
Clinical Journal of the American Society of Nephrology. 12:1778-1786
Background and objectives Avoiding nonsteroidal anti-inflammatory drugs is important for safe CKD care. This study examined nonsteroidal anti-inflammatory drug use patterns and their association with other analgesic use in CKD. Design, setting, parti
Autor:
Jeffery C. Fink, Shoshana Weiner
Publikováno v:
Advances in Chronic Kidney Disease. 24:31-38
Chronic kidney disease (CKD) patients have several features conferring upon them a high risk of adverse safety events, which are defined as incidents with unintended harm related to processes of care or medications. These characteristics include impa
Publikováno v:
Journal of managed carespecialty pharmacy. 22(8)
Nephrotoxic medication exposure increases risks for acute kidney injury, permanent renal function loss, and costly preventable adverse drug events. Exposure to medications associated with inducing acute tubular nephritis or tubular toxicity versus no